A novel GLP-1 receptor agonist (RA) pill called orforglipron leads to a larger reduction in blood sugar levels after a year than the current available oral GLP-1 RA (semaglutide), finds a phase 3 ...
Galderma (SIX: GALD) will present ten posters with the latest updates from across its broad aesthetic portfolio spanning regenerative biostimulation, HA and neuromodulator treatments at the ...
Clinicians frequently rely on expert opinions, which are sometimes later disproven by randomised controlled trials (RCTs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results